MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Net loss$3,670K (110.17%↑ Y/Y)Loss onextinguishment of note payable-$3,354K Proceeds from sale ofproperty and equipment$416K Depreciation expense$2,452K (194.71%↑ Y/Y)Prepaid expenses andother assets-$475K (-182.75%↓ Y/Y)Stock-based compensationexpense$419K (-88.97%↓ Y/Y)Non-cash interestexpense$176K (-82.57%↓ Y/Y)Loss on sale anddisposal of property and...-$159K Non-cash lease expense$89K (-76.64%↓ Y/Y)Net cash used inoperating activities$6,629K (119.43%↑ Y/Y)something is missing$3,662K Net cash provided byinvesting activities$416K Canceled cashflow$4,165K Net decrease incash, cash...-$25,367K (24.78%↑ Y/Y)Canceled cashflow$10,707K Operating lease liability-$2,769K (-191.17%↓ Y/Y)Gain on modificationof lease liability$1,142K Accounts payable,accrued expenses and...-$221K (90.59%↑ Y/Y)Change in fair value ofderivative liability$33K (-82.63%↓ Y/Y)Net cash (used in)provided by financing...-$36,074K (-9397.42%↓ Y/Y)Repayment of note payableand extinguishment...$32,413K Proceeds from at themarket offering of...-$3,621K (-1143.52%↓ Y/Y)Proceeds from issuancesunder employee stock...-$40K (-197.56%↓ Y/Y)
Cash Flow

Werewolf Therapeutics, Inc. (HOWL)

Werewolf Therapeutics, Inc. (HOWL)

source: myfinsight.com